Ain’t Too Proud to Beg: Pricing Lessons from the Rolling Stones

Have you seen the recent headlines about sky high ticket prices for the Rolling Stones and the resulting slow sales?  It’s embarrassing and yet again reinforces how important pricing is to a company.

The truth is on occasion, we all overshoot on prices. Please check out my latest piece for the Harvard Business Review that discusses how to handle this situation in a manner that both preserves your brand and profitable sells your product.

Posted on May 14th, 2013 (0 Comments)

Solving the $100,000 Cancer Drug Problem

Last week leading cancer researchers wrote an op-ed on $100,000 cancer drugs – describing how this high price tag impedes treatment and questioning the morality of pharmaceutical companies. It sounds counterintuitive, but I think the key to making drugs more affordable is to encourage pharmaceutical companies to make more money.

Please check out my latest blog for the Harvard Business Review which discusses this “win-win” pricing opportunity.

Posted on May 2nd, 2013 (0 Comments)

With Ron Johnson Out, What Should J.C. Penney Do Now?

Yesterday J.C. Penney and its CEO, Ron Johnson, parted ways. Now the big question is what should J.C. Penney do now?

Please check out my latest online piece for the Harvard Business Review which discusses this unstable situation and what actions I believe J.C. Penney should take.

Also, please check out my interview on NPR's Morning Edition on this topic.

As always, many thanks for your readership and comments are welcome!

Posted on April 9th, 2013 (0 Comments)